100 £

Kamagra Super is a fixed-dose combination tablet that pairs sildenafil citrate (for erectile dysfunction) with dapoxetine hydrochloride (for premature ejaculation). The idea is straightforward: one ingredient helps improve erection quality by supporting blood flow during sexual stimulation, while the other is a short-acting SSRI used in some countries to help increase time to ejaculation and improve control. iMedix explains this “two-problem, one approach” concept in plain English, without the typical confusion and hype.

What makes this page especially useful is that it doesn’t just tell you what it’s for—it helps you understand what to realistically expect and what to be careful with. Kamagra Super is commonly found in the 100 mg sildenafil / 60 mg dapoxetine format, and iMedix clearly notes key context: this combination product is not FDA-approved, and dapoxetine is not licensed for medical use in the U.S. That matters because the biggest risk isn’t only side effects—it’s also quality and consistency when products are obtained outside regulated pharmacy channels.

iMedix also puts safety front and center in a way that’s easy to act on. Because Kamagra Super combines two active ingredients, the interaction list is more serious than with a standard ED medication. The page highlights major red-flags like nitrates (dangerous blood-pressure drop), other serotonergic medications (higher risk of serotonin-related complications), and alcohol (can significantly increase dizziness and fainting risk with dapoxetine). If you’re the type who wants to feel informed before making any decision, iMedix gives you the warnings, FAQs, and user reviews in one place—so you’re not relying on random comments online.